2025
SJR Q2
JCR Q3 · 2,5
100 matched articles
SCIE
Journal detail
Infectious Diseases
- Publisher
- Taylor and Francis Ltd.
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
2374423523744243
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,733
- Quartile Q2
- H-Index 87
- Cites/doc 2,19
- Docs (3y) 344
- Cites (3y) 697
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,5
- 5Y JIF 2,7
- JCI 0,64
WoS indexes
- SCIE
Subject classification
Categories (SJR)
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,733 | 2,5 | 2,7 | 0,64 | Q3 | 87 |
| 2024 | Q1 | Q3 | 0,957 | 2,3 | 3 | 0,73 | Q2 | 84 |
| 2023 | Q1 | Q1 | 0,954 | 4 | 3,7 | 0,79 | Q2 | 84 |
| 2022 | Q1 | Q1 | 1,146 | 5,8 | 4,3 | 0,82 | Q2 | 84 |
| 2021 | Q2 | Q2 | 0,799 | 5,8 | 4 | 0,68 | Q2 | 84 |
| 2020 | Q2 | Q3 | 0,727 | 3,4 | 2,6 | 0,64 | Q3 | 84 |
| 2019 | Q2 | Q3 | 0,832 | 2,5 | 2,2 | 0,61 | Q3 | 84 |
| 2018 | — | Q3 | — | 2,2 | 2,1 | 0,56 | Q3 | — |
| 2017 | Q2 | Q3 | 0,863 | 1,9 | 1,9 | 0,54 | Q3 | 84 |
| 2016 | Q2 | Q4 | 0,781 | 1,1 | 1,1 | — | — | 84 |
| 2015 | Q2 | — | 0,789 | — | — | — | — | 84 |
| 2014 | Q2 | — | 0,784 | — | — | — | — | 84 |
| 2013 | Q2 | — | 0,83 | — | — | — | — | 84 |
| 2012 | Q2 | — | 0,767 | — | — | — | — | 84 |
| 2011 | Q2 | — | 0,754 | — | — | — | — | 84 |
| 2010 | Q2 | — | 0,724 | — | — | — | — | 84 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | INFECTIOUS DISEASES | SCIE | Q3 | Q3 | 77/141 |
| 2024 | INFECTIOUS DISEASES | SCIE | Q3 | Q2 | 76/137 |
| 2023 | INFECTIOUS DISEASES | SCIE | Q1 | Q2 | 31/132 |
| 2022 | INFECTIOUS DISEASES | SCIE | Q1 | Q2 | 22/96 |
| 2021 | INFECTIOUS DISEASES | SCIE | Q2 | Q2 | 31/95 |
| 2020 | INFECTIOUS DISEASES | SCIE | Q3 | Q3 | 50/93 |
| 2019 | INFECTIOUS DISEASES | SCIE | Q3 | Q3 | 57/92 |
| 2018 | INFECTIOUS DISEASES | SCIE | Q3 | Q3 | 61/89 |
| 2017 | INFECTIOUS DISEASES | SCIE | Q3 | Q3 | 65/88 |
| 2016 | INFECTIOUS DISEASES | SCIE | Q4 | — | 79/84 |
| 2015 | INFECTIOUS DISEASES | SCIE | — | — | — |